Editas Medicine (EDIT) Enterprise Value Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.76% |
| Sep 30, 2025 | 26.64% |
| Jun 30, 2025 | 26.66% |
| Mar 31, 2025 | 23.23% |
| Dec 31, 2024 | 18.57% |
| Sep 30, 2024 | 21.96% |
| Jun 30, 2024 | 22.97% |
| Mar 31, 2024 | 22.05% |
| Dec 31, 2023 | 7.03% |
| Sep 30, 2023 | 10.96% |
| Jun 30, 2023 | 10.31% |
| Mar 31, 2023 | 8.45% |
| Dec 31, 2022 | 9.02% |
| Sep 30, 2022 | -8.05% |
| Jun 30, 2022 | -12.49% |
| Mar 31, 2022 | -12.60% |
| Dec 31, 2021 | -10.65% |
| Sep 30, 2021 | -18.24% |
| Jun 30, 2021 | -21.07% |
| Mar 31, 2021 | -20.34% |
| Dec 31, 2020 | -6.90% |
| Sep 30, 2020 | -18.76% |
| Jun 30, 2020 | -22.61% |
| Mar 31, 2020 | -5.69% |
| Dec 31, 2019 | -35.12% |
| Sep 30, 2019 | -18.50% |
| Jun 30, 2019 | -13.46% |
| Mar 31, 2019 | -14.28% |
| Dec 31, 2018 | -63.67% |
| Sep 30, 2018 | -29.53% |
| Jun 30, 2018 | -94.12% |
| Mar 31, 2018 | -311.06% |